A detailed history of Convergence Investment Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 8,940 shares of JNJ stock, worth $1.31 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
8,940
Previous 6,713 33.17%
Holding current value
$1.31 Million
Previous $1.05 Million 34.41%
% of portfolio
0.54%
Previous 0.55%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$155.22 - $162.74 $345,674 - $362,421
2,227 Added 33.17%
8,940 $1.41 Million
Q4 2023

Feb 05, 2024

BUY
$145.6 - $158.88 $4,950 - $5,401
34 Added 0.51%
6,713 $1.05 Million
Q3 2023

Nov 02, 2023

BUY
$155.75 - $174.48 $20,559 - $23,031
132 Added 2.02%
6,679 $1.04 Million
Q2 2023

Jul 26, 2023

SELL
$154.35 - $166.11 $15,898 - $17,109
-103 Reduced 1.55%
6,547 $1.08 Million
Q1 2023

May 09, 2023

SELL
$151.05 - $180.26 $39,575 - $47,228
-262 Reduced 3.79%
6,650 $1.03 Million
Q4 2022

Feb 03, 2023

BUY
$160.2 - $179.79 $1,281 - $1,438
8 Added 0.12%
6,912 $1.22 Million
Q3 2022

Nov 08, 2022

BUY
$161.33 - $179.52 $155,522 - $173,057
964 Added 16.23%
6,904 $1.13 Million
Q2 2022

Aug 05, 2022

SELL
$168.19 - $186.01 $321,915 - $356,023
-1,914 Reduced 24.37%
5,940 $1.05 Million
Q1 2022

Apr 26, 2022

BUY
$158.14 - $179.59 $46,493 - $52,799
294 Added 3.89%
7,854 $1.39 Million
Q4 2021

Jan 25, 2022

SELL
$155.93 - $173.01 $58,005 - $64,359
-372 Reduced 4.69%
7,560 $1.29 Million
Q3 2021

Oct 25, 2021

BUY
$161.5 - $179.47 $32,461 - $36,073
201 Added 2.6%
7,932 $1.28 Million
Q2 2021

Jul 19, 2021

SELL
$159.48 - $171.07 $77,826 - $83,482
-488 Reduced 5.94%
7,731 $1.27 Million
Q1 2021

Apr 30, 2021

BUY
$153.07 - $170.48 $57,248 - $63,759
374 Added 4.77%
8,219 $1.35 Million
Q4 2020

Feb 05, 2021

SELL
$137.11 - $157.38 $705,156 - $809,405
-5,143 Reduced 39.6%
7,845 $1.24 Million
Q3 2020

Oct 28, 2020

SELL
$140.38 - $153.83 $80,437 - $88,144
-573 Reduced 4.23%
12,988 $1.93 Million
Q2 2020

Jul 30, 2020

BUY
$128.81 - $155.51 $195,533 - $236,064
1,518 Added 12.6%
13,561 $1.91 Million
Q1 2020

Apr 23, 2020

BUY
$111.14 - $153.99 $592,042 - $820,304
5,327 Added 79.32%
12,043 $1.58 Million
Q4 2019

Jan 22, 2020

SELL
$127.5 - $146.44 $8,160 - $9,372
-64 Reduced 0.94%
6,716 $980,000
Q3 2019

Oct 22, 2019

SELL
$126.95 - $142.14 $5,966 - $6,680
-47 Reduced 0.69%
6,780 $877,000
Q2 2019

Jul 23, 2019

SELL
$131.15 - $144.24 $1.61 Million - $1.77 Million
-12,271 Reduced 64.25%
6,827 $951,000
Q1 2019

May 01, 2019

BUY
$125.72 - $139.79 $1.57 Million - $1.75 Million
12,484 Added 188.75%
19,098 $2.67 Million
Q4 2018

Feb 13, 2019

BUY
$122.84 - $147.84 $80,214 - $96,539
653 Added 10.95%
6,614 $853,000
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $132,400 - $155,596
1,089 Added 22.35%
5,961 $824,000
Q2 2018

Aug 07, 2018

SELL
$119.4 - $131.76 $21,730 - $23,980
-182 Reduced 3.6%
4,872 $591,000
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $50,040 - $59,255
400 Added 8.59%
5,054 $648,000
Q4 2017

Jan 16, 2018

BUY
$131.22 - $143.62 $7,610 - $8,329
58 Added 1.26%
4,654 $650,000
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $595,044 - $622,206
4,596
4,596 $598,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $383B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Convergence Investment Partners, LLC Portfolio

Follow Convergence Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.